Relating to the establishment of a grant program to fund the United States Food and Drug Administration's drug development trials with ibogaine for the purpose of securing the administration's approval as a medication for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy.

89th Legislature (2025) Introduced by Daniel Alders and 33 co-sponsors

Texas would fund FDA drug trials for ibogaine addiction treatment, attempting to accelerate a controlled substance's federal approval through state-level grant investment.

Laid on the table subject to call

#alcoholism&drugabuse(i0030) #crimes--drugs(i0185) #health&humanservicescommission(v0177) #health--general(i0385) #medicine&prescriptiondrugs(s7338) #research&development(s0135) #statefinances--appropriations(i0746)